Penn Radiology – Oncologic Imaging Essentials 2020
medicalvideo.store
$ v.option1 == myState.option1 && v.option2 == myState.option2 && v.option3 == myState.option3)[0].variantPrice || 'selected options not available'">45.00
Description
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
Penn Radiology – Oncologic Imaging Essentials 2020
Topics And Speakers:
Session 1: Head and Neck
Viral-Induced Neoplasia of the Head and Neck | Laurie A. Loevner, MD |
Laryngeal Cancer: What the Clinician Needs to Know | Laurie A. Loevner, MD |
PET/CT in Head and Neck Cancer: Pearls and Pitfalls | Laurie A. Loevner, MD |
TI-RADS and Thyroid Cancer Detection | Jill Langer, MD |
Orbital Neoplasia Patterns of Spread | Laurie A. Loevner, MD |
Robotics in Head and Neck Cancer: Emphasis on Oropharyngeal Cancer | Laurie A. Loevner, MD |
Session 2: Body Imaging I: Abdomen and Prostate
Imaging of Upper GI Tract Tumors | Susan L. Summerton, MD |
Imaging of GU Tract Malignancies | Susan L. Summerton, MD |
Incidentalomas on Abdominal Imaging | Susan L. Summerton, MD |
Prostate Cancer Update | Jill Langer, MD |
Session 3: Breast
Digital Breast Tomosynthesis: Today and Tomorrow | Samantha P. Zuckerman, MD |
Update on Screening MR – Not Just for BRCA Patients | Samantha P. Zuckerman, MD |
Management of High Risk Breast Lesions | Samantha P. Zuckerman, MD |
Imaging Special Populations | Samantha P. Zuckerman, MD |
Challenging Cases in Breast Imaging | Samantha P. Zuckerman, MD |
Session 4: Body Imaging II: GYN and Colonography
Non-Ovarian GYN Malignancy- What Role Does the Radiologist Play? | Jill Langer, MD |
Ovarian Cancer Screening | Jill Langer, MD |
Screening for Colon Cancer: Role of CT Colonograpy | Susan L. Summerton, MD |
Pre- and Post-Operative Imaging of the Colon | Susan L. Summerton, MD |
Session 5: Nuclear Medicine Indications and Applications
Accepted Indications for FDG PET/CT | Daniel A. Pryma, MD |
Pearls and Pitfalls in FDG PET/CT | Daniel A. Pryma, MD |
FDG PET/CT in Response Assessment: Solid Tumors, Lymphoma, and Immunotherapy | Daniel A. Pryma, MD |
Beyond FDG: PET/CT with Ga-68 DOTATATE, F-18 Fluciclovine, and PSMA | Daniel A. Pryma, MD |
The Role of Nuclear Medicine in Thyroid Disease | Daniel A. Pryma, MD |
Challenging Nuclear Medicine Cases | Daniel A. Pryma, MD |
Release Date: 4/15/20
CME Expiration: 4/14/23